Advanced Therapies Integrates 2024

26th November 2024


  • TRACK 1: A Digital Revolution & A Person-Centric Approach

Proudly Sponsored by:

Cell and Gene Therapy Catapult CPI Mills & Reeve Cytiva Rentschler Biopharma Stevenage Borough Council


08:30 - 09:30
Registration and Networking
09:30 - 09:40
Welcome & Opening remarks
09:40 - 10:00
Fireside chat: For the people who need them
A patient group presentation exploring the patient-perspective on the importance of innovations, new gene therapies, and what ATMPs mean for the people, families and communities we’re developing them for.

A Digital Revolution & A Person-Centric Approach

10:05 - 10:50

Make them better

Digital technologies offer new opportunities to overcome key challenges in ATMP manufacturing, such as quality control, efficiency and sustainability. How is the UK embracing these opportunities to make ATMPs faster and more efficiently?

10:50 – 11:20

Networking Coffee Break

Headline Sponsor:

11:20 - 12:05

It’s an upskill battle

Manufacturing ATMPs requires advanced and constantly evolving skills. How can industry and government work together to ensure the UK has the skilled workforce needed for the growth of the ATMP sector?

12:10 - 12:55

Hub-ble Bubble

The UK is home to world-class innovation hubs and science parks. How do these hubs support the collaboration and sharing of facilities and expertise required for successful ATMP development?

12:55 – 13:55

Networking Lunch

Gold and Silver Sponsors:

13:55 - 14:40

In sickness and in health

A thriving ATMP sector that meets today’s health challenges relies on effective partnerships. Working with the right cell & gene outsourcing partner ensures quality and safety, and smooths out financial and regulatory challenges. How do you find the right partner and work in tandem to maintain a productive relationship?

14:45 – 15:30

Funding battles

In the current economic environment, both public and private funders are tightening their purse strings. How can we demonstrate the health and economic benefits that would come from a return to previous levels of funding for the ATMP sector?

15:35 - 16:05

Investing in our health

We need to get advanced therapies to the people who need them rapidly and cost-effectively. How can we improve the bench to bedside journey to cut costs and improve efficiencies? How can we ensure the UK sees ATMPs as an investment in our health and economy?

16:05 – 17:05

Networking Drinks Reception

Bronze Sponsors:


GSK, Stevenage

GSK, Stevenage

GSK, Stevenage

The R&D hub in Stevenage is home to more than 2,500 GSK people focused on discovering and developing new medicines.

The Stevenage Campus base is home to other major organisations including Stevenage Bioscience Catalyst, the Cell and Gene Therapy Manufacturing Catapult, LifeArc and Cytiva alongside a growing cluster of start-up companies.


By car:
– 20-minute drive to Luton

By train:

-21 minutes from Kings Cross
-35 Minutes from Cambridge

Please click here for directions.



GSK, Gunnels Wood Rd, Stevenage SG1 2NFX

All sponsors